Skip to main
AMTX

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Aemetis is a renewable fuel and biochemicals company with a strong 5-year financial plan to reach $1 billion in revenue in 2026. Key upcoming catalysts include progress on biogas and cellulosic ethanol production facilities, potential IPO of its India business, and positive regulatory paths for expanded E15 fuel usage and dairy digester RNG pathways. While the company has a history of losses, recent financial progress and potential future developments make it an attractive investment opportunity with significant upside potential.

Bears say

Aemetis is expected to continue struggling with a high level of debt and tight liquidity, which could put pressure on its financial performance in the near future. Additionally, the company's 2026 revenue and EPS estimates have been lowered, and while there is potential for improved operations and a positive outlook, they may not materialize given the company's history of losses and challenges in maintaining liquidity. The company has promising opportunities for growth, but its high leverage and external uncertainties pose significant risks.

Aemetis (AMTX) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Aemetis (AMTX) has a Strong Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $22, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $22, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.